Medtronic (MDT) Tops Q4 EPS by 6c; Sees Larger FX Impact in FY16
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Intel shares fall as competitor reports record results
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- SanDisk shares fall on election and chip sector pressure
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Wedbush Raised Price Target on Medtronic (MDT) Following FY16 Guidance; Maintains Neutral
June 3, 2015 9:03 AM EDTWedbush maintains a Neutral rating on Medtronic, Inc. (NYSE: MDT), and raised the price target to $79.00 (from $75.00), following Q4 results and guidance. MDT reported FY4Q15 revenue of $7.3 billion (as preannounced). Reported adjusted EPS of $1.16 was 3c ahead of the upper end of its... More
Medtronic (MDT) PT Bumped to $91 at Needham & Company Post Q4
June 2, 2015 1:08 PM EDTNeedham & Company analyst Mike Matson reiterated a Buy rating and bumped his price target on Medtronic, Inc. (NYSE: MDT) to $91.00 (from $90.00) following Q4 results.
Analyst Matson commented, "MDT's F4Q15 revenue was consistent with its 5/20/15 preannouncement while its EPS came in ahead of... More



